AAPL341.15+4.48 (+1.33%) ▲|ABBV271.83+0.47 (+0.17%) ▲|ABT98.49-0.24 (-0.24%) ▼|ACN208.40+11.76 (+5.98%) ▲|ADBE241.05+8.28 (+3.56%) ▲|AMAT509.57-11.08 (-2.13%) ▼|AMD620.68-25.18 (-3.90%) ▼|AMGN407.44-5.64 (-1.37%) ▼|AMT166.77+0.59 (+0.35%) ▲|AMZN254.06-5.86 (-2.25%) ▼|AVGO360.14-16.37 (-4.35%) ▼|AXP307.98+3.73 (+1.23%) ▲|BA187.77-0.55 (-0.29%) ▼|BAC53.59+0.07 (+0.13%) ▲|BKNG159.97+4.10 (+2.63%) ▲|BLK1,065.59-4.04 (-0.38%) ▼|BMY59.56-0.14 (-0.23%) ▼|BNY143.61+0.89 (+0.62%) ▲|BRK-B511.10+4.85 (+0.96%) ▲|C128.08+0.76 (+0.59%) ▲|CAT796.17-17.66 (-2.17%) ▼|CL88.12+0.91 (+1.04%) ▲|CMCSA21.21+0.27 (+1.29%) ▲|COF199.40+3.49 (+1.78%) ▲|COP134.20+4.36 (+3.36%) ▲|COST947.92+5.67 (+0.60%) ▲|CRM227.70+3.14 (+1.40%) ▲|CSCO114.89-2.50 (-2.13%) ▼|CVS87.82-0.13 (-0.15%) ▼|CVX211.59+6.44 (+3.14%) ▲|DE652.52-4.35 (-0.66%) ▼|DHR217.46-1.03 (-0.47%) ▼|DIS107.06+2.31 (+2.21%) ▲|DUK116.82+1.32 (+1.14%) ▲|EMR159.07-0.15 (-0.09%) ▼|FDX291.67+2.63 (+0.91%) ▲|GD329.93+3.30 (+1.01%) ▲|GE305.61+1.99 (+0.66%) ▲|GEV998.97+1.88 (+0.19%) ▲|GILD147.10+0.25 (+0.17%) ▲|GM82.26+1.27 (+1.57%) ▲|GOOG344.86-2.51 (-0.72%) ▼|GOOGL348.29-2.21 (-0.63%) ▼|GS881.51-5.70 (-0.64%) ▼|HD295.44+9.67 (+3.38%) ▲|HON206.60-1.51 (-0.73%) ▼|IBM226.59+6.08 (+2.76%) ▲|INTC107.08-6.04 (-5.34%) ▼|INTU303.88+8.02 (+2.71%) ▲|ISRG415.41+0.89 (+0.21%) ▲|JNJ256.49-1.96 (-0.76%) ▼|JPM331.45+1.87 (+0.57%) ▲|KO87.77+1.95 (+2.27%) ▲|LIN481.70-2.28 (-0.47%) ▼|LLY1,169.93-18.79 (-1.58%) ▼|LMT507.96+8.74 (+1.75%) ▲|LOW188.85+7.31 (+4.03%) ▲|LRCX320.59-8.92 (-2.71%) ▼|MA574.74+4.68 (+0.82%) ▲|MCD236.87+5.99 (+2.59%) ▲|MDLZ60.67+1.29 (+2.17%) ▲|MDT87.71+2.20 (+2.58%) ▲|META720.89-0.42 (-0.06%) ▼|MMM163.60+1.48 (+0.91%) ▲|MO71.42+2.04 (+2.93%) ▲|MRK142.40-0.40 (-0.28%) ▼|MS187.43-2.28 (-1.20%) ▼|MSFT522.61-7.15 (-1.35%) ▼|MU1,035.84-52.16 (-4.79%) ▼|NEE77.37+0.31 (+0.40%) ▲|NFLX71.57+1.87 (+2.68%) ▲|NKE34.75+0.39 (+1.12%) ▲|NOW139.74+1.87 (+1.36%) ▲|NVDA230.48-6.99 (-2.94%) ▼|ORCL135.56-8.01 (-5.58%) ▼|PEP128.34+4.61 (+3.73%) ▲|PFE27.83-0.17 (-0.61%) ▼|PG150.60+2.78 (+1.88%) ▲|PLTR198.78+4.66 (+2.40%) ▲|PM200.51+7.82 (+4.06%) ▲|QCOM176.01-1.11 (-0.63%) ▼|RTX184.29+4.03 (+2.24%) ▲|SBUX93.21-0.37 (-0.40%) ▼|SCHW96.88+1.30 (+1.36%) ▲|SO86.14+0.70 (+0.82%) ▲|SPG199.61+2.02 (+1.02%) ▲|T24.89+0.42 (+1.70%) ▲|TMO651.74-10.33 (-1.56%) ▼|TMUS171.31+3.66 (+2.18%) ▲|TSLA375.00-2.81 (-0.74%) ▼|TXN288.20-0.78 (-0.27%) ▼|UBER70.25+1.80 (+2.62%) ▲|UNH370.73-5.25 (-1.40%) ▼|UNP278.19+3.51 (+1.28%) ▲|UPS94.11+1.82 (+1.97%) ▲|USB57.03+0.86 (+1.52%) ▲|V375.12+3.02 (+0.81%) ▲|VZ46.36+0.59 (+1.28%) ▲|WFC82.04+1.78 (+2.22%) ▲|WMT110.56+2.40 (+2.22%) ▲|XOM168.56+4.51 (+2.75%) ▲|AAPL341.15+4.48 (+1.33%) ▲|ABBV271.83+0.47 (+0.17%) ▲|ABT98.49-0.24 (-0.24%) ▼|ACN208.40+11.76 (+5.98%) ▲|ADBE241.05+8.28 (+3.56%) ▲|AMAT509.57-11.08 (-2.13%) ▼|AMD620.68-25.18 (-3.90%) ▼|AMGN407.44-5.64 (-1.37%) ▼|AMT166.77+0.59 (+0.35%) ▲|AMZN254.06-5.86 (-2.25%) ▼|AVGO360.14-16.37 (-4.35%) ▼|AXP307.98+3.73 (+1.23%) ▲|BA187.77-0.55 (-0.29%) ▼|BAC53.59+0.07 (+0.13%) ▲|BKNG159.97+4.10 (+2.63%) ▲|BLK1,065.59-4.04 (-0.38%) ▼|BMY59.56-0.14 (-0.23%) ▼|BNY143.61+0.89 (+0.62%) ▲|BRK-B511.10+4.85 (+0.96%) ▲|C128.08+0.76 (+0.59%) ▲|CAT796.17-17.66 (-2.17%) ▼|CL88.12+0.91 (+1.04%) ▲|CMCSA21.21+0.27 (+1.29%) ▲|COF199.40+3.49 (+1.78%) ▲|COP134.20+4.36 (+3.36%) ▲|COST947.92+5.67 (+0.60%) ▲|CRM227.70+3.14 (+1.40%) ▲|CSCO114.89-2.50 (-2.13%) ▼|CVS87.82-0.13 (-0.15%) ▼|CVX211.59+6.44 (+3.14%) ▲|DE652.52-4.35 (-0.66%) ▼|DHR217.46-1.03 (-0.47%) ▼|DIS107.06+2.31 (+2.21%) ▲|DUK116.82+1.32 (+1.14%) ▲|EMR159.07-0.15 (-0.09%) ▼|FDX291.67+2.63 (+0.91%) ▲|GD329.93+3.30 (+1.01%) ▲|GE305.61+1.99 (+0.66%) ▲|GEV998.97+1.88 (+0.19%) ▲|GILD147.10+0.25 (+0.17%) ▲|GM82.26+1.27 (+1.57%) ▲|GOOG344.86-2.51 (-0.72%) ▼|GOOGL348.29-2.21 (-0.63%) ▼|GS881.51-5.70 (-0.64%) ▼|HD295.44+9.67 (+3.38%) ▲|HON206.60-1.51 (-0.73%) ▼|IBM226.59+6.08 (+2.76%) ▲|INTC107.08-6.04 (-5.34%) ▼|INTU303.88+8.02 (+2.71%) ▲|ISRG415.41+0.89 (+0.21%) ▲|JNJ256.49-1.96 (-0.76%) ▼|JPM331.45+1.87 (+0.57%) ▲|KO87.77+1.95 (+2.27%) ▲|LIN481.70-2.28 (-0.47%) ▼|LLY1,169.93-18.79 (-1.58%) ▼|LMT507.96+8.74 (+1.75%) ▲|LOW188.85+7.31 (+4.03%) ▲|LRCX320.59-8.92 (-2.71%) ▼|MA574.74+4.68 (+0.82%) ▲|MCD236.87+5.99 (+2.59%) ▲|MDLZ60.67+1.29 (+2.17%) ▲|MDT87.71+2.20 (+2.58%) ▲|META720.89-0.42 (-0.06%) ▼|MMM163.60+1.48 (+0.91%) ▲|MO71.42+2.04 (+2.93%) ▲|MRK142.40-0.40 (-0.28%) ▼|MS187.43-2.28 (-1.20%) ▼|MSFT522.61-7.15 (-1.35%) ▼|MU1,035.84-52.16 (-4.79%) ▼|NEE77.37+0.31 (+0.40%) ▲|NFLX71.57+1.87 (+2.68%) ▲|NKE34.75+0.39 (+1.12%) ▲|NOW139.74+1.87 (+1.36%) ▲|NVDA230.48-6.99 (-2.94%) ▼|ORCL135.56-8.01 (-5.58%) ▼|PEP128.34+4.61 (+3.73%) ▲|PFE27.83-0.17 (-0.61%) ▼|PG150.60+2.78 (+1.88%) ▲|PLTR198.78+4.66 (+2.40%) ▲|PM200.51+7.82 (+4.06%) ▲|QCOM176.01-1.11 (-0.63%) ▼|RTX184.29+4.03 (+2.24%) ▲|SBUX93.21-0.37 (-0.40%) ▼|SCHW96.88+1.30 (+1.36%) ▲|SO86.14+0.70 (+0.82%) ▲|SPG199.61+2.02 (+1.02%) ▲|T24.89+0.42 (+1.70%) ▲|TMO651.74-10.33 (-1.56%) ▼|TMUS171.31+3.66 (+2.18%) ▲|TSLA375.00-2.81 (-0.74%) ▼|TXN288.20-0.78 (-0.27%) ▼|UBER70.25+1.80 (+2.62%) ▲|UNH370.73-5.25 (-1.40%) ▼|UNP278.19+3.51 (+1.28%) ▲|UPS94.11+1.82 (+1.97%) ▲|USB57.03+0.86 (+1.52%) ▲|V375.12+3.02 (+0.81%) ▲|VZ46.36+0.59 (+1.28%) ▲|WFC82.04+1.78 (+2.22%) ▲|WMT110.56+2.40 (+2.22%) ▲|XOM168.56+4.51 (+2.75%) ▲|
23.7 C
New York
Thursday, October 8, 2026

Tag: news

Subsea 7 S.A. Notice of Extraordinary General Meeting

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW

Subsea7 and Saipem announce signing of the Merger Agreement

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW 

A New Chapter of Bold Leadership and Unstoppable Growth

LEHI, Utah, July 23, 2025 /CNW/ -- Amare Global, The Mental Wellness Company™, is pleased to announce a powerful new chapter; effective immediately, David...

FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Action – Hagens Berman

SAN FRANCISCO, July 23, 2025 (GLOBE NEWSWIRE) -- When, on May 27, 2025, Rocket Pharmaceuticals (NASDAQ: RCKT) revealed that the FDA put a clinical hold on its Phase 2 pivotal trial for RP-A501, an experimental therapy intended to treat patients with a rare gene disorder called Danon disease, investors in the company’s shares saw their investment crash over 60% that day.

Cboe Plans to Cease Japanese Equities Operations

Cboe will maintain presence in Japan for its Global Derivatives and Cboe Data Vantage businessesCHICAGO and TOKYO, July 23, 2025 /PRNewswire/ -- Cboe Global Markets,...

Claudin 18.2-Directed Oncology Therapeutics–A Fast-Growing Market with Blockbuster Potential | DelveInsight

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering,...

Claudin 18.2-Directed Oncology Therapeutics–A Fast-Growing Market with Blockbuster Potential | DelveInsight

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering,...

Martello and Wesley Clover International Amend Loan Agreement

Amendment extends the loan's maturity date to 2028 at a fixed interest rate of 12%. /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR...

Cambiar Thrive’s “Big Ideas Challenge” Aims to Fuel Student Success by Closing the Education Information Gap for Students and Families

New Funding Opportunity Seeks Catalytic Solutions to Address Data Demand SAN DIEGO, July 23, 2025 /PRNewswire/ -- Cambiar Education, with support from the Walton Family...

LGI Homes Unveils New Townhome Plans at Cottonwood Greens in Fort Lupton, Colorado

LGI Homes is proud to announce the debut of five brand-new townhome floor plans at Cottonwood Greens, located northeast of Denver in Fort Lupton.

The Roche Associates, Inc. Named “Top Senior Living Marketing Agency 2025”

East Longmeadow, MA, July 23, 2025 (GLOBE NEWSWIRE) -- The Roche Associates, Inc. was recently named “Top Senior Living Marketing Agency for 2025” by Elder Care Review. The Roche Associates, Inc. emerged as the Top Senior Living Marketing Agency for 2025” after an extensive evaluation by an expert panel of C-level executives, industry thought leaders, and Elder Care Review’s editorial board. Elder Care Review is a monthly magazine, focused on the senior housing and senior care industries. Elder Care Review magazine has 113,000 qualified print and digital subscribers (41k print and 72k digital).

CORE LAB REPORTS SECOND QUARTER 2025 RESULTS

REVENUE OF $130.2 MILLION, UP 5% SEQUENTIALLY AND FLAT YEAR-OVER-YEAROPERATING INCOME OF $15.3 MILLION; EX-ITEMS, $14.5 MILLION, UP OVER 23% SEQUENTIALLY AND DOWN 11%...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsNews